Senolytics are considered an anti-aging medication, and they’re currently used to treat a range of health conditions. And new ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild ...

Alzheon's Alzheimer's drug showed nominal benefit in a subgroup of patients who suffer with mild cognitive impairment.

Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission: Tokyo Wednesday, April 16, 2025, 11:00 Hrs [I ...

Senolytics are considered an anti-aging medication ... they develop protein clumps in the brain, called amyloid-beta plaques. There are two enzymes found near these plaques, called ...

The pharma industry's dogged determination to develop amyloid-targeting therapies for ... four times the benefit reported for Eli Lilly's anti-amyloid drug solanezumab at the same clinical ...

CERN’s LHCb experiment confirms CP violation in baryons, marking a milestone in particle physics; Japan unveils the world’s ...